S. Vincent Rajkumar MD FRCPC

PubMed

• Measurable residual disease assessment in multiple myeloma.
  Saurabh Zanwar, S Vincent Rajkumar
  Leukemia. 2025-12-05
• Final OS analyses from the TOURMALINE- MM3 and -MM4 RCTs of ixazomib maintenance in newly diagnosed multiple myeloma.
  Meletios A Dimopoulos, Sagar Lonial, Wee-Joo Chng, Shinsuke Iida, María-Victoria Mateos
  Blood Cancer Journal. 2025-12-04
• Clinical Characteristics, Treatment Responses and Outcomes of Light Chain Multiple Myeloma.
  Abiola Bolarinwa, Saurabh Zanwar, Nadine Abdallah, Francis K Buadi, Suzanne R Hayman
  American Journal of Hematology. 2025-12-01

Journal Articles

• Impact of Prior Diagnosis of Monoclonal Gammopathy on Outcomes in Newly Diagnosed Multiple Myeloma  
  S Vincent Rajkumar, Yi L Hwa, Wilson I Gonsalves, Francis K Buadi, Angela Dispenzieri, Prashant Kapoor, Miriam A Hobbs, Martha Q Lacy, John A Lust, Robert A Kyle, Mori..., Nature
• Relapse After Complete Response in Newly Diagnosed Multiple Myeloma: Implications of Duration of Response and Patterns of Relapse  
  Angela Dispenzieri, Francis K Buadi, Morie A Gertz, Martha Q Lacy, Nelson Leung, Amie L Fonder, Wilson I Gonsalves, Yi Lisa Hwa, Taxiarchis Kourelis, Surbhi Sidana, Ro..., Nature
• Primary Systemic Amyloidosis in Patients with Waldenström Macroglobulinemia  
  Angela Dispenzieri, Eli Muchtar, Ronald Go, Saurabh Zanwar, Surbhi Sidana, Francis Buadi, Stephen M Ansell, Prashant Kapoor, David Dingli, Thomas Habermann, Shaji Kuma..., Nature

Books/Book Chapters

• Cecil Textbook of Medicine 
  Chapter: Plasma Cell Disorders 
  Rajkumar SVElsevierEdition 25th,2016
• Multiple Myeloma: Diagnosis and Treatment 
  Morie A. Gertz, S. Vincent Rajkumar (eds)Springer2013
• Abeloff's Clinical Oncology 
  Chapter: Multiple Myeloma and Related Disorders 
  S. Vincent RajkumarElsevierEdition 5th,2013

Abstracts/Posters

• Mortality of Patients with Multiple Myeloma after the Introduction of Novel Therapies in the United States
  S. Vincent Rajkumar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Phase 2 Trial of Daratumumab, Ixazomib, Lenalidomide and Modified Dose Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma
  Vincent Rajkumar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Germline Variation Predicts Treatment Response in Multiple Myeloma
  S. Vincent Rajkumar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

• Approaches To Achieve the Best Possible Outcomes in Myeloma 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Long-Term Survivorship with Active Multiple Myeloma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Ibrutinib Therapy in Patients with Waldenstrom Macroglobulinemia: Outcomes Outside of Clinical Trial Setting 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018